Inozyme Pharma Stock (NASDAQ:INZY), Quotes and News Summary

Q: What sector and industry does Inozyme Pharma (INZY) operate in?

Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.

Open	$4.430
Close	-
Volume / Avg.	288.022K / 663.410K
Day Range	4.430 - 4.620
52 Wk Range	2.689 - 7.795
Market Cap	$274.268M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	4.21%
Days to Cover	2.93

Recent News

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

Avi Kapoor

Top 5 Health Care Stocks That May Plunge In March

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Avi Kapoor

Inozyme Pharma Posts Encouraging Data From Rare Calcification Disorders

Inozyme Pharma Inc (NASDAQ: INZY) announced interim safety, pharmacokinetic (PK), pharmacodynamic (PD), and exploratory efficacy data from its ongoing Phase 1/2 trials of INZ-701 in adults with

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Inozyme Pharma Inc

Sector

Health Care

Industry

Biotechnology

Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutic...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Inozyme Pharma (INZY) stock?

You can purchase shares of Inozyme Pharma (NASDAQ: INZY) through any online brokerage.

View our list of the best stock brokerages.

Who are Inozyme Pharma's (INZY) competitors?

Other companies in Inozyme Pharma’s space includes: Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), Tevogen Bio Holdings (NASDAQ:TVGN), Opthea (NASDAQ:OPT) and Monte Rosa Therapeutics (NASDAQ:GLUE).

What is the target price for Inozyme Pharma (INZY) stock?

The latest price target for Inozyme Pharma (NASDAQ: INZY) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 23.00 expecting INZY to rise to within 12 months (a possible 418.02% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for Inozyme Pharma (INZY)?

The stock price for Inozyme Pharma (NASDAQ: INZY) is $4.44 last updated Today at April 23, 2024 at 11:50 AM EDT.

Does Inozyme Pharma (INZY) pay a dividend?

There are no upcoming dividends for Inozyme Pharma.

When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?

Inozyme Pharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Inozyme Pharma (INZY) going to split?

There is no upcoming split for Inozyme Pharma.

What sector and industry does Inozyme Pharma (INZY) operate in?

Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-